Sanofi to acquire Synthorx for $2.5 billion By: MarketWatch December 09, 2019 at 02:09 AM EST The French pharmaceutical company said it plans to take control of all outstanding shares of Synthorx for $68 per share in cash. Read More >> Related Stocks: Sanofi-Aventis S.A. ADR Synthorx Inc